Pulseline

@{site-date-dd} @{site-date-month} @{site-date-yyyy}

Latest Pulseline Newsletter

MTAA will be closed from Thursday 22nd December 2016 at 3pm and will re-open Monday 9th January 2017 at 9am.

What's New?

Image

MTAA appoints new Chief Executive Officer
Chairman of Medical Technology Association of Australia (MTAA), Gavin Fox-Smith, today announced at the Annual-General Meeting the appointment of Ian Burgess as its next Chief Executive Officer. Mr Burgess will step into the role from Monday 30th January 2017.

Read our media release

Image

MTAA looking for an Industry Policy Advisor in 2017

We're hiring! MTAA are looking for an Industry Policy Adviser to join us in 2017.

The Industry Policy Adviser will assist in identifying specific strategies and policies to support the growth of the Australian domestic medical technology industry.  If you have 5 years policy experience in and around government we would love to hear from you. 

See full job decription

Image

New OTP Training in 2017

Due to demand, we are adding more OTP training courses for Medical Company Representatives (MCRs) in 2017.

1.5 Introduction to Operating Theatre Protocols (20th January 2017, Sydney)

1.5 Introduction to Operating Theatre Protocols (24th February 2017, Sydney)

1.5 Introduction to Operating Theatre Protocols (5th May 2017, Sydney)

 
If you are interested in booking these dates or negotiating a separate training date in your state, please contact MTAA Professional Development Manager, Lee Grow at lgrow@mtaa.org.au

Image

Code of Practice Update

Our members were reminded last week of the MTAA monitoring process and the data that is requested from companies each year. This process is based on the Medical Technology Industry Code of Practice that our members undertake to abide by as a condition of membership. It ensures the unique relationship between companies and healthcare professionals is based on trust, integrity and the primacy of patient well-being. The annual monitoring reports members submit to MTAA on their activities (within scope of the Code), are fundamental to supporting the Code to meet its intended purpose.

 

Download examples of the report you will be asked to complete and details of items you will be asked for information in 2017.

Industry News

Image

Privately insured patients missing out on medical technologies

Recently in the Daily Telegraph the Medical Technology of Australia (MTAA) calls on the Government to change the definition of what can be included on the Prostheses List (PL).

 

Presently, a benefit is only payable in respect of surgically implanted prostheses, human tissue items and other medical devices list.  

Read our media release

Image

February Prostheses List 2017 key dates

The Department of Health has released important dates for the upcoming February 2017 Prostheses list.

  • Early January – initial draft of February Prostheses list(items considered at January PLAC meeting are not included) is circulated to sponsors and suppliers for corrections
  • 27th January – final draft of February Prostheses list(items considered at the January PLAC meeting are included)is circulated to sponsors and suppliers to make final corrections.
  • 28th February – Private Health insurance(Prostheses) rules No 1(2017) is published.

Read more

Image

Gift giving under the Medical Technology Code of Practice

Approaching the festive and holiday season, there have been some reports about inappropriate gift giving.

 

No formal complaints have been lodged however, we would like to kindly remind everyone that the interactions companies have with Healthcare Professionals should abide by the Code.

 

Besides the monetary value, items provided to Healthcare Professionals should be for the benefit of patients or serve an educational purpose. 

 

We would encourage everyone to read the FAQs about gifts on our website, www.mtaa.org.au/gifts.

 

If you have any questions, please feel to contact code@mtaa.org.au

Image

$500 million Biomedical Translation Fund announced

The Turnbull Government is today launching the $500 million Biomedical Translation Fund, established under the government’s National Innovation and Science Agenda, which will help take Australian biomedical discoveries out of the laboratory and to the patient.

 

Three experienced venture capital fund managers have been selected to help turn biomedical discoveries into high growth potential companies which will benefit Australian patients.

Read more

Image

Innovation Launch

Innovation Launch is looking for solutions to issues in NSW.  If you have a solution that is nearing market readiness, our program can offer you up to $150k in funding, equity free and with no requirement for matched funds. What is more, NSW government could be your first customer.

Read more

 

Regulation Sandboxes

The next big disruptions will likely not be accommodated by our regulatory framework. If you have a big idea, and are working on it right now, work with us in disrupting NSW regulations. Our Regulatory Sandboxes program offers the chance to test your idea in partnership with our regulatory bodies.

Read more

External Opportunities

Image

Australian Healthcare Week 2017

As we enter a transformational period of change for health and aged care provision in Australia, with advances in technology and new models of care, Australian Healthcare Week is the best-on-offer event in 2017 to provide you with the solutions to the challenges you will face in the design and delivery of the healthcare facilities of today and tomorrow.

 

Join us in March 8-10, 2017 as we bring Australian Healthcare Week to the heart of Sydney’s meeting district at the new International Convention Centre, Darling Harbour. 

Read more

P (+612) 9900 0600

F (+612) 9900 0655

E Reception@mtaa.org.au

 Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.


© 2016 Medical Technology Association of Australia, All rights reserved.
This e-mail is for the use of the intended recipient(s) only. If you have received this e-mail in error, please notify the sender immediately and then delete it. If you are not the intended recipient, you must not use, disclose or distribute this e-mail without the author's permission.